News & Events
PRESS RELEASE
May 4, 2026
Rejoni Appoints Women’s Health MedTech Leader John Nealon as Chief Executive Officer
A seasoned executive with more than two decades of leadership experience in women’s health and medical devices, Mr. Nealon brings a distinguished record of building high-performing teams, driving commercial growth, and delivering patient-centered solutions to market.
PRESS RELEASE
Jan 13, 2026
FDA Files Rejoni’s Juveena® Hydrogel System PMA for the Prevention of Intrauterine Adhesions
The Juveena Hydrogel System is designed as a temporary spacer to help prevent the formation and reformation of intrauterine adhesions (IUAs). The PMA submission includes results from a pivotal clinical study in patients undergoing transcervical procedures, including adhesiolysis and fibroid removal.
TRADESHOW
Nov 13-16, 2026
AAGL 2026 55th Annual Global Congress on MIGS
Hynes Convention Center
Boston, Massachusetts